Reported Earlier, Argenx Announced The Presentation Of New Data For Vyvgart In Myasthenia Gravis (MG) And Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) At The 2026 American Academy Of Neurology (AAN) Annual Meeting In Chicago From April 18-22, 2026